Omega-3 fatty acid supplementation provides an additional benefit to a low-dust diet in the management of horses with chronic lower airway inflammatory disease.
- Journal Article
- Randomized Controlled Trial
- Research Support
- Non-U.S. Gov't
- Airway Disease
- Animal Health
- Bronchoalveolar Lavage
- Clinical Signs
- Clinical Study
- Dietary Supplements
- Disease Treatment
- Equine Health
- Fatty Acids
- Horses
- Immune Response
- Inflammation
- Inflammatory Response
- Lung Health
- Nutrition
- Plasma
- Recurrent Airway Obstruction
- Respiratory Disease
- Veterinary Medicine
- Veterinary Research
Summary
This research suggests that supplementing horses’ diets with Omega-3 fatty acid could help manage chronic lower airway inflammatory diseases. The study found that, when combined with a low-dust diet, horses suffering from chronic respiratory diseases experienced significant improvements in their symptoms.
Research Objective
The objective of this study was to evaluate the complementarity of Omega-3 polyunsaturated fatty acids (PUFA) supplementation in the management of horses suffering from recurrent airway obstruction (RAO) and inflammatory airway disease (IAD). The researchers hypothesized that integrating a specific amount of PUFA in their daily meals could significantly improve clinical signs, lung functions, and airway inflammation.
Methodology
- The study involved eight research horses and 35 client-owned horses. Initially, a pilot study was carried out to determine the right amount of PUFA that could alter plasma PUFA composition.
- Following that, a randomized controlled test was conducted, in which horses were kept on a diet of complete pellets with zero hay. These horses were segregated into three groups, each subject to a different treatment for two months: 30g or 60g of the supplement, or 30g of a placebo.
- The study monitored several parameters such as clinical signs, lung function, plasma PUFA composition, and bronchoalveolar lavage fluid (BALF) cytology to measure the impact of the treatments.
Results
- The study found that PUFA supplementation led to an increase in plasma docosahexaenoic acid (DHA) levels, which hit their peak after four weeks.
- While all horses on the clinical trial displayed some level of improvement, the group on PUFA supplements showed more substantial progress in terms of reduced coughing (improvement by 60%), improved lung function (reduction in respiratory effort by 48%), and decreased BALF neutrophils (from 23% to 9%).
- The placebo group also showed improvement; however, the effect wasn’t as pronounced, with cough score only improved by 33%, respiratory effort decreased by 27%, and BALF neutrophils increasing rather than decreasing (from 11% to 17%).
Conclusions
The research concluded that giving horses with RAO and IAD a PUFA supplement that contains 1.5-3g DHA per day for two months could add a significant benefit to a low-dust diet. However, further research may be needed to understand the optimal dosage and other potential benefits or side-effects of such dietary supplements in horses.
Cite This Article
Publication
Researcher Affiliations
- Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, IN.
MeSH Terms
- Animal Feed / analysis
- Animal Nutritional Physiological Phenomena
- Animals
- Bronchoalveolar Lavage Fluid / cytology
- Chronic Disease
- Dietary Supplements
- Dose-Response Relationship, Drug
- Dust
- Fatty Acids, Omega-3 / administration & dosage
- Fatty Acids, Omega-3 / pharmacology
- Female
- Horse Diseases / drug therapy
- Horses
- Inflammation / veterinary
- Lung Diseases, Obstructive / drug therapy
- Lung Diseases, Obstructive / veterinary
- Male
- Pilot Projects
References
- Couëtil LL, Hoffman AM, Hodgson J. Inflammatory airway disease of horses.. J Vet Intern Med 2007;21:356–361.
- Hotchkiss JW, Reid SW, Christley RM. A survey of horse owners in Great Britain regarding horses in their care. Part 2: Risk factors for recurrent airway obstruction.. Equine Vet J 2007;39:301–308.
- Robinson NE, Karmaus W, Holcombe SJ. Airway inflammation in Michigan pleasure horses: Prevalence and risk factors.. Equine Vet J 2006;38:293–299.
- Couëtil LL, Chilcoat CD, DeNicola DB. Randomized, controlled study of inhaled fluticasone propionate, oral administration of prednisone, and environmental management of horses with recurrent airway obstruction.. Am J Vet Res 2005;66:1665–1674.
- Bertin FR, Ivester KM, Couëtil LL. Comparative efficacy of inhaled albuterol between two hand‐held delivery devices in horses with recurrent airway obstruction.. Equine Vet J 2011;43:393–398.
- Wood JL, Newton JR, Chanter N, Mumford JA. Inflammatory airway disease, nasal discharge and respiratory infections in young British racehorses.. Equine Vet J 2005;37:236–242.
- Holcombe SJ, Jackson C, Gerber V. Stabling is associated with airway inflammation in young Arabian horses.. Equine Vet J 2001;33:244–249.
- Ivester KM, Couëtil LL, Moore GE. Environmental exposures and airway inflammation in young thoroughbred horses.. J Vet Intern Med 2014;28:918–924.
- Kirschvink N, Smith N, Fiévez L. Effect of chronic airway inflammation and exercise on pulmonary and systemic antioxidant status of healthy and heaves‐affected horses.. Equine Vet J 2002;34:563–571.
- Xie J, Zhang Q, Zhong N, Lai K. BAL fluid 8‐isoprostane concentrations in‐eosinophilic bronchitis and asthma.. J Asthma 2009;46:712–715.
- Kadiiska MB, Gladen BC, Baird DD. Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic Biol Med 2005;38:698–710.
- Calder PC. n‐3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.. Am J Clin Nutr 2006;83(6 Suppl):1505S–1519S.
- Lane K, Derbyshire E, Li W, Brennan C. Bioavailability and potential uses of vegetarian sources of omega‐3 fatty acids: A review of the literature.. Crit Rev Food Sci Nutr 2014;54:572–579.
- Kang JX, Weylandt KH. Modulation of inflammatory cytokines by omega‐3 fatty acids.. Subcell Biochem 2008;49:133–143.
- Giudetti AM, Cagnazzo R. Beneficial effects of n‐3 PUFA on chronic airway inflammatory diseases.. Prostaglandins Other Lipid Mediat 2012;99:57–67.
- Mueller RS, Fettman MJ, Richardson K. Plasma and skin concentrations of polyunsaturated fatty acids before and after supplementation with n‐3 fatty acids in dogs with atopic dermatitis.. Am J Vet Res 2005;66:868–873.
- Leemans J, Cambier C, Chandler T. Prophylactic effects of omega‐3 polyunsaturated fatty acids and luteolin on airway hyperresponsiveness and inflammation in cats with experimentally‐induced asthma.. Vet J 2010;184:111–114.
- Vineyard KR, Warren LK, Kivipelto J. Effect of dietary omega‐3 fatty acid source on plasma and red blood cell membrane composition and immune function in yearling horses.. J Anim Sci 2010;88:248–257.
- Khol‐Parisini A, van den Hoven R, Leinker S. Effects of feeding sunflower oil or seal blubber oil to horses with recurrent airway obstruction.. Can J Vet Res 2007;71:59–65.
- Gerber V, Schott Ii HC, Robinson NE. Owner assessment in judging the efficacy of airway disease treatment.. Equine Vet J 2011;43:153–158.
- Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues.. J Biol Chem 1957;226:497–509.
- Juaneda P, Rocquelin G. Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges.. Lipids 1985;20:40–41.
- Antalis CJ, Stevens LJ, Campbell M. Omega‐3 fatty acid status in attention‐deficit/hyperactivity disorder.. Prostaglandins Leukot Essent Fatty Acids 2006;75:299–308.
- Couëtil LL, Rosenthal FS, DeNicola DB, Chilcoat CD. Clinical signs, evaluation of bronchoalveolar lavage fluid, and assessment of pulmonary function in horses with inflammatory respiratory disease.. Am J Vet Res 2001;62:538–546.
- Van Breukelen GJP. ANCOVA versus change from baseline had more power in randomized studies and more bias in nonrandomized studies.. J Clin Epidemiol 2006;59:920–925.
- Leclere M, Lavoie‐Lamoureux A, Lavoie JP. Heaves, an asthma‐like disease of horses.. Respirology 2011;16:1027–1046.
- Robinson NE, Berney CB, Eberhart S. Coughing, mucus accumulation, airway obstruction, and airway inflammation in control horses and horses affected with recurrent airway obstruction.. Am J Vet Res 2003;64:550–557.
- Lavoie JP, Phan ST, Blais D. Effects of a combination of detomidine and butorphanol on respiratory function in horses with or without chronic obstructive pulmonary disease.. Am J Vet Res 1996;57:705–709.
- Broadstone RV, Gray PR, Robinson NE, Derksen FJ. Effects of xylazine on airway function in ponies with recurrent airway obstruction.. Am J Vet Res 1992;53:1813–1817.
- Art T, Kirschvink N, Smith N, Lekeux P. Indices of oxidative stress in blood and pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction.. Equine Vet J 1999;31:397–401.
- Kubáň P, Foret F. Exhaled breath condensate: Determination of non‐volatile compounds and their potential for clinical diagnosis and monitoring. A review.. Anal Chim Acta 2013;17:1–18.
- Healy DA, Wallace FA, Miles EA. Effect of low‐to‐moderate amounts of dietary fish oil on neutrophil lipid composition and function.. Lipids 2000;35:763–768.
- King SS, Abughazaleh AA, Webel SK, Jones KL. Circulating fatty acid profiles in response to three levels of dietary omega‐3 fatty acid supplementation in horses.. J Anim Sci 2008;86:1114–1123.
- Brinsko SP, Varner DD, Love CC. Effect of feeding a DHA‐enriched nutriceutical on the quality of fresh, cooled and frozen stallion semen.. Theriogenology 2005;63:1519–1527.
- Barrager E, Veltmann JR, Schauss AG, Schiller RN. A multicentered, open‐label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis.. J Altern Complement Med 2002;8:167–173.
- Tecklenburg SL, Mickleborough TD, Fly AD. Ascorbic acid supplementation attenuates exercise‐induced bronchoconstriction in patients with asthma.. Respir Med 2007;101:1770–1778.
- Bailey SR. Corticosteroid‐associated laminitis.. Vet Clin North Am Equine Pract 2010;26:277–285.
- Derksen FJ. Chronic obstructive pulmonary disease (heaves) as an inflammatory condition.. Equine Vet J 1993;25:257–258.